Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113956208A reveals a metal-free, Eosin Y-catalyzed arylation method offering cost reduction in pharmaceutical intermediate manufacturing and scalable green chemistry solutions.
Optimized synthesis of 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid via copper catalysis. Reduces heavy metal residue and cost for API manufacturing.
Patent CN103333049A reveals a recyclable phosphotungstic acid ionic liquid catalyst for styrene oxide alcoholysis, offering high purity and reduced waste for pharmaceutical intermediate manufacturing.
Patent CN102153501A details a metal-free organocatalytic synthesis of chiral pyrrolidines and piperidines with high enantioselectivity, offering cost-effective routes for pharmaceutical intermediates.
Patent CN113527081B reveals a safer Mitsunobu route for 3-oxocyclobutanecarboxylic acid. Discover cost reduction in pharma intermediate manufacturing and scalable supply solutions.
Patent CN111732612A reveals a stable iron-carborane catalyst for synthesizing trans-2-alkenylazaarenes, offering cost reduction in API manufacturing and mild reaction conditions.
Patent CN109438308B reveals a green ultrasound-assisted synthesis for high-purity organoselenium intermediates, offering significant cost reduction and supply chain reliability.
Patent CN111138315B reveals a scalable Ag-catalyzed route for cyanoalkyl quinones, replacing costly photocatalysis for efficient pharmaceutical intermediate manufacturing.
Patent CN102633738A details a novel chiral zinc complex synthesis. This report analyzes its cost-effective production and catalytic utility for pharmaceutical intermediates.
Patent CN114411182A reveals a green electrocatalytic route for alpha-carbonyl sulfoxide ylide dichloride, offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Patent CN116574039B details a novel cyanation method offering regioselectivity and reduced toxicity for pharmaceutical intermediates. This process enables significant cost reduction and supply chain reliability for global buyers.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN106995461B reveals a novel benzofuran phosphine ligand enhancing Suzuki-Miyaura coupling yields up to 99% for efficient pharmaceutical intermediate manufacturing and supply chain stability.
Patent CN116041393B reveals a novel N-N axis chiral ligand offering superior stereoselectivity and cost-effective synthesis for asymmetric catalysis applications.
Patent CN112680497A reveals enzymatic splitting for high-purity Corey lactone. Achieve significant cost reduction in API intermediate manufacturing and supply reliability.
Patent CN107445989B discloses novel indole-based phosphine ligands offering high catalytic activity for C-S bond formation, ensuring cost-effective pharmaceutical intermediate manufacturing.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Novel copper-catalyzed ring-opening allylation of cyclopropanols offers high-yield, green route for pharmaceutical intermediates and complex molecule synthesis.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN111892528A details a regioselective Ru-catalyzed C-H amidation method, offering cost-effective routes for high-purity pharmaceutical intermediates and scalable API manufacturing.